iScience (May 2025)

Autocrine/paracrine lysophosphatidylserine signaling suppresses B cell aggregation and tertiary lymphoid structure formation

  • Akiharu Uwamizu,
  • Yuji Shinjo,
  • Jumpei Omi,
  • Manae Tatstumi,
  • Kuniyuki Kano,
  • Kumiko Makide,
  • Hajime Kitamura,
  • Michiyo Okudaira,
  • Keita Satoh,
  • Fumiya Fukami,
  • Tasuku Kawano,
  • Tomomitsu Miyasaka,
  • Tomoko Takahashi,
  • Osamu Nakajima,
  • Tomohiko Ohwada,
  • Asuka Inoue,
  • Junken Aoki

DOI
https://doi.org/10.1016/j.isci.2025.112420
Journal volume & issue
Vol. 28, no. 5
p. 112420

Abstract

Read online

Summary: Accumulating evidence suggests that Gα13 signaling by G protein-coupled receptors negatively regulate B cell function. We report here that lysophosphatidylserine (LysoPS), an emerging immunoregulatory lysophospholipid, is produced upon B cell activation and suppresses B cell adhesive properties via its Gα13-coupled receptors, LPS2 and LPS2L. B cell activation in vitro markedly increased the LysoPS level thereby inhibiting cell aggregation in a LysoPS receptor-dependent manner. In T cell-dependent antigen immunization and asthma models, LPS2/2L double knock-out mice exhibited increased B cell number with early and enhanced formation of germinal center (GC) and tertiary lymphoid structures (TLS)-like structures, in addition to an elevated antibody level and worsened conditions. We thus propose a novel regulatory mechanism for lymphocyte aggregation in which LysoPS on B cells acts in an autocrine/paracrine fashion to inhibit GC and TLS formation by disrupting B cell-B cell or B cell-T cell interactions via Gα13 signaling.

Keywords